Erratum to: Vitamin D Status and Bone Mineral Density Changes During Alendronate Treatment in Postmenopausal Osteoporosis

被引：0
|
作者：
Christian Roux
Neil Binkley
Steven Boonen
Douglas P. Kiel
Stuart H. Ralston
Jean-Yves Reginster
Annpey Pong
Elizabeth Rosenberg
Arthur Santora
机构：
[1] Paris Descartes University,Institute for Aging Research
[2] University of Wisconsin,Institute of Genetics and Molecular Medicine, Western General Hospital
[3] Center for Metabolic Bone Disease,undefined
[4] Hebrew SeniorLife and Harvard Medical School,undefined
[5] University of Edinburgh,undefined
[6] University of Liege,undefined
[7] Merck Sharp and Dohme,undefined
来源：
Calcified Tissue International | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：158 / 158
相关论文
共 50 条
  • [31] Oral alendronate increases bone mineral density and reduces vertebral fracture incidence in postmenopausal osteoporosis
    Meunier, PJ
    [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 : 15 - 19
  • [32] Abaloparatide Followed by Alendronate on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis and Osteoarthritis
    Lane, Nancy
    Weiss, Richard
    Mitlak, Bruce
    Wang, Yamei
    Valenzuela, Guillermo
    Deal, Chad
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [33] CORRELATION OF VITAMIN D AND BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN
    Saridogan, M.
    Akarirmak, U.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 277 - 277
  • [34] The Influence of Vitamin D Receptor Genetic Variants on Bone Mineral Density and Osteoporosis in Chinese Postmenopausal Women
    He, Wei
    Liu, Ming
    Huang, Xiaonan
    Qing, Zuhong
    Gao, Wei
    [J]. DISEASE MARKERS, 2015, 2015
  • [35] Comparison of the effects of denosumab with either active vitamin D or native vitamin D on bone mineral density and bone turnover markers in postmenopausal osteoporosis
    Suzuki, Takako
    Nakamura, Yukio
    Tanaka, Mizue
    Kamimura, Mikio
    Ikegami, Shota
    Uchiyama, Shigeharu
    Kato, Hiroyuki
    [J]. MODERN RHEUMATOLOGY, 2018, 28 (02) : 376 - 379
  • [36] Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis
    Nuti, R
    Bianchi, G
    Brandi, ML
    Caudarella, R
    D'Erasmo, E
    Fiore, C
    Isaia, GC
    Luisetto, G
    Muratore, M
    Oriente, P
    Ortolani, S
    [J]. RHEUMATOLOGY INTERNATIONAL, 2006, 26 (05) : 445 - 453
  • [37] Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis
    R. Nuti
    G. Bianchi
    M.L. Brandi
    R. Caudarella
    E. D’Erasmo
    C. Fiore
    G.C. Isaia
    G. Luisetto
    M. Muratore
    P. Oriente
    S. Ortolani
    [J]. Rheumatology International, 2006, 26 : 445 - 453
  • [38] The effects of minodronate and activated vitamin D on bone mineral density and muscle mass in postmenopausal women with osteoporosis
    Fujimoto, Kazuki
    Inage, Kazuhide
    Toyoguchi, Toru
    Eguchi, Yawara
    Orita, Sumihisa
    Yamauchi, Kazuyo
    Suzuki, Miyako
    Kubota, Gou
    Sainoh, Takeshi
    Sato, Jun
    Shiga, Yasuhiro
    Abe, Koki
    Kanamoto, Hirohito
    Inoue, Masahiro
    Kinoshita, Hideyuki
    Norimoto, Masaki
    Umimura, Tomotaka
    Koda, Masao
    Furuya, Takeo
    Nakamura, Junichi
    Akazawa, Tsutomu
    Terakado, Atsushi
    Takahashi, Kazuhisa
    Ohtori, Seiji
    [J]. SPINE SURGERY AND RELATED RESEARCH, 2018, 2 (02): : 148 - 153
  • [39] Influence of vitamin D levels on bone mineral density and osteoporosis
    Sadat-Ali, Mir
    Al Elq, Abdulmohsen H.
    Al-Turki, Haifa A.
    Al-Mulhim, Fathma A.
    Al-Ali, Amein K.
    [J]. ANNALS OF SAUDI MEDICINE, 2011, 31 (06) : 602 - 608
  • [40] BONE MINERAL DENSITY DISORDERS IN POSTMENOPAUSAL OSTEOPOROSIS
    Abboskhujaeva, L. S.
    Alikhanova, N. M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S86 - S86
12345